Clinical Trial Update: Deferoxamine and Xingnaojing Injection Treatment in Intracerebral Hemorrhage [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on a Phase 1/2 study of Deferoxamine plus Xingnaojing Injection for intracerebral hemorrhage; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage

Drugs mentioned

• Deferoxamine (deferoxamine)
• XingNaoJing injection (XingNaoJing)

Snippet

Sponsor: Capital Medical University | Conditions: Intracerebral Hemorrhage | Phase 1, Phase 2 | Status: UNKNOWN